Adriano Venditti - Researcher Profile

Publications

2 shown

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

Gerrit Jan Schuurhuis , Michael Heuser , Sylvie Freeman +21 more

Abstract Measurable residual disease (MRD; previously termed minimal residual disease) is an independent, postdiagnosis, prognostic indicator in acute myeloid leukemia (AML) tha...

2018 Blood 991 citations

Prognostic relevance of limit of quantification as low-level cutoff for flow cytometry-based measurable residual disease assessment in acute myeloid leukemia

Lukas H. Haaksma , Raffaele Palmieri , Tom Reuvekamp +16 more

2025 Leukemia 0 citations

Frequent Co-Authors

Researcher Info

h-index: 1
Publications: 2
Citations: 991
Institution: University of Rome Tor Vergata

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-0245-0553

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.